Zobrazeno 1 - 10
of 103
pro vyhledávání: ''
Autor:
Alexander Link, Elvan Yilmaz, Katrin Borucki, Ali Canbay, Jan-Peter Sowa, Mustafa Porsch-Özcürümez, Sitke Aygen, Aline Gottlieb, AS Leven
Publikováno v:
Digestion. 102:671-681
Background and Aim: Nonalcoholic fatty liver disease (NAFLD) affects about 25% of the global population, with no reliable noninvasive tests to diagnose nonalcoholic steatohepatitis (NASH) and to differentiate between NASH and nonalcoholic fatty liver
Autor:
Yoshikazu Hayashi, Yoshimasa Miura, Alan Kawarai Lefor, Hirotsugu Sakamoto, Satoshi Shinozaki, Hiroyuki Osawa, Yasutoshi Kobayashi, Hironori Yamamoto
Publikováno v:
Digestion. 101:382-390
Background/Aims: The long-term outcomes of patients after cessation of acotiamide therapy in patients with functional dyspepsia remains unclear. The aim of this study is to investigate the timing and predictors of recurrence of dyspepsia symptoms aft
Autor:
Ken Inoue, Takayuki Katayama, Kohei Oka, Yuki Minagawa, Yuki Endo, Akihiro Nagata, Satoshi Sugino, Toshiyuki Komaki, Takashi Okuda, Takayuki Ota, Yoshito Itoh, Chihiro Yasue, Yuji Naito, Toshifumi Tsuji, Keizo Kagawa, Hideki Nakamura
Publikováno v:
Digestion. 101:323-331
Background and Aims: We examined the efficacy of the combined use of L-menthol spraying (L-mentholS) as an antispasmodic agent and carbon dioxide insufflation (CO2I) on the adenoma detection rate (ADR) in a prospective, single-center trial with a 2
Autor:
Kenichiro Takahashi, Akira Andoh, Masahiro Kawahara, Atsushi Nishida, Yasuhiro Morita, Mitsushige Sugimoto, Osamu Inatomi, Shigeki Bamba, Masaya Sasaki
Publikováno v:
Digestion. 100:238-246
Background/Aims: Thiopurines are key drugs in maintenance therapy for treating inflammatory bowel disease (IBD). Time-dependent 5-aminosalicylates (5-ASA) releasing preparations (time-dependent 5-ASA) increase 6-thioguanine nucleotide (6-TGN), an act
Autor:
Hideo Baba, Takahiko Akiyama, Yukiharu Hiyoshi, Naoya Yoshida, Shiro Iwagami, Yoshifumi Baba, Yuki Kiyozumi, Yuji Miyamoto, Kojiro Eto, Nagai Yohei
Publikováno v:
Digestion. 99:79-85
Background: Regorafenib and TAS-102 are standard salvage-line treatment options for patients with chemorefractory metastatic colorectal cancer (mCRC). We aimed to evaluate the prognostic significance of skeletal muscle mass in mCRC patients receiving
Publikováno v:
Digestion. 99:213-218
Background: An effective bowel cleanse can improve the imaging quality of video capsule endoscopy (VCE). We aimed to further investigate the optimal small bowel cleanse method by comparing the efficacy of 4 L of clear liquids, 2 L of polyethylene gly
Publikováno v:
Digestion. 99:179-184
Background: Sorafenib has shown efficacy in patients with imatinib-, sunitinib-, and regorafenib-resistant gastrointestinal stromal tumors (GISTs). No biomarker is currently available for predicting response to sorafenib in patients with GIST. Method
Autor:
Gionata Fiorino, Mariangela Allocca, Alessandro Armuzzi, Silvio Danese, Federica Furfaro, Alfredo Papa, Laurent Peyrin-Biroulet, Rosario Landi, Antonino Spinelli, Stefanos Bonovas
Publikováno v:
Digestion. 96:166-172
Background: Most Crohn's disease (CD) patients develop endoscopic recurrence within one year of intestinal resection. The best treatment method to prevent post-operative CD recurrence remains uncertain. Methods: A total of 155 CD patients from 2 refe
Publikováno v:
Digestion. 96:110-118
Background: Several of the drugs in development for treatment of nonalcoholic steatohepatitis (NASH) target liver fibrosis or have side effects that prohibit their long-term use in patients with mild to moderate disease. Lunasin is a soy-derived pept
Autor:
Akihito Nagahara, Mariko Hojo, Yuji Shimada, Kohei Matsumoto, Sumio Watanabe, Daisuke Asaoka, Kenshi Matsumoto, Hiroya Ueyama, Shuko Nojiri, Kentaro Izumi, Tsutomu Takeda
Publikováno v:
Digestion. 96:5-12
Background/Aims: Acotiamide, a prokinetic drug, is used to treat functional dyspepsia (FD), especially postprandial distress syndrome (PDS). However, a treatment for FD patients with PDS and/or epigastric pain syndrome (EPS) has not been established.